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Mesenchymal stem cells (MSCs) possess great therapeutic potential. Efficient in vitro expansion of MSCs is however necessary for
their clinical application. The extracellular matrix (ECM) provides structural and biochemical support to the surrounding cells,
and it has been used as a coating substrate for cell culture. In this study, we have aimed to improve the functionality and stemness
of MSCs during culture using poly-L-lysine (PLL). Functionality of MSCs was analysed by cell cycle analysis, differentiation assay,
𝛽-galactosidase staining, and RT-PCR. Furthermore, we assessed the global gene expression profile of MSCs on uncoated and
PLL-coated plates. MSCs on PLL-coated plates exhibited a faster growth rate with increased S-phase and upregulated expression
of the stemness markers. In addition, their osteogenic differentiation potential was increased, and genes involved in cell adhesion,
FGF-2 signalling, cell cycle, stemness, cell differentiation, and cell proliferation were upregulated, compared to that of the MSCs
cultured on uncoated plates. We also confirmed that MSCs on uncoated plates expressed higher 𝛽-galactosidase than the MSCs on
PLL-coated plates. We demonstrate that PLL provides favourable microenvironment for MSC culture by reversing the replicative
senescence. This method will significantly contribute to effective preparation of MSCs for cellular therapy.
1. Introduction
The differentiation of mesenchymal stem cells (MSCs) into
multiple cell lineages can be exploited as an attractive strat-
egy for cell-based therapy and regenerative medicine [1].
MSCs can easily be obtained from various human tissue
sources such as the bone marrow, cord blood, placenta, and
adipose [2–5]. The clinical application of MSCs to tissue
engineering has been introduced due to their numerous
advantages including high expansion potential and extensive
differentiation potential [6, 7]. However, MSCs need to be
expanded in vitro in order to obtain sufficient cells for clinical
trials since they are extremely rare in various tissues. Unlike
embryonic stem cells, adult stem cells (MSCs) have a limited
lifespan and stop proliferating during in vitro culture due to
replicative senescence [8].
Cellular senescence, which is morphologically charac-
terized by an enlarged and flattened cell shape, was first
described by Hayflick [9]. Cellular senescence refers to active
cells that eventually enter a state of irreversible growth arrest.
Moreover, replicative senescence of MSCs exhibits reduced
functionality, and cellular senescencemight impair the regen-
erative potential of MSCs [10]. Studies investigating MSC
senescence are therefore crucial for successful therapeutic
application ofMSCs.Themechanisms underlying the cellular
senescence ofMSCs are still poorly understood. Studies show
that replicative senescence or cellular senescence is induced
by intrinsic or extrinsic environmental factors [11].The short-
ening of telomeres constitutes an intrinsic factor, whereas
DNA damage is considered an extrinsic factor. Specifically,
oxidative stress by reactive oxygen species (ROS) is the main
extrinsic factor that induces senescence [12]. Cellular senes-
cence is a complex process, and itsmolecularmechanisms are
unknown. A number of studies demonstrated that hypoxia
is beneficial to the senescence of MSC; however the precise
understanding mechanism is not clear [13–15]. It was also
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shown that inhibition of the p16 tumour suppressor gene
delays growth arrest and therefore senescence of MSC [16].
Additionally, Abedin andKing showed that FGF-2 suppresses
the cellular senescence of human MSCs [17]. It is hard to
preserve the important characteristics such as proliferation
capacity and stemness of MSCs the inadequate cultivating
microenvironment in vitro. Therefore, establishing an opti-
mized culture condition that delays the senescence of MSCs
is imperative.
MSCs naturally reside in a specialized niche in vivo,
which mainly consists of the extracellular matrix (ECM).The
ECMprovides structural and biochemical support to the cells
and has various other functions including cell adhesion, cell
to cell communication, and differentiation [17, 18]. Poly-L-
lysine (PLL) of extracellular matrix proteins is a small natural
homopolymer of the essential amino acid L-lysine that is used
to coat culture substrates. PLL functions as an attachment
factor that enhances cell adherence due to its strong affinity
for proteins and electrostatic interactions between the pos-
itive charges on the PLL molecule and the negative charges
on the cell membrane [19, 20]. Park et al. showed that PLL
increases the ex vivo expansion and erythroid differentiation
of human hematopoietic stem cells [21]. It was also reported
that PLL promoted neural progenitor cell function, and it is
commonly used for MSC differentiation into neural lineages
[22]. Recent studies suggest that neuroectodermal cells can
generate MSCs, and they may arise in the neural crest, which
is derived from embryonic neuroectoderm [23, 24]. These
studies emphasized the interesting possibility that PLL could
provide a favourable environment for MSC culture in vitro.
We therefore hypothesized that PLL would be beneficial for
MSC culture expansion and would preserve MSC properties
in vitro. In this study, PLL-coated plates were used for
MSC culture expansion. To the best of our knowledge,
this study is the first to compare genome-wide expression
profiles of MSCs cultured on PLL-coated plates with MSCs
cultured on uncoated plates. In addition, we compared
and analysed properties of MSCs cultured on PLL-coated
plates with uncoated plates.The PLL-coated surface provided
an excellent environment that improved the stemness of
MSCs and delayed their senescence through upregulation of
genes involved in cell adhesion, FGF-2 signaling, cell cycle,
stemness, cell differentiation, and proliferation. This method
could be useful for in vitro expansion of highly functional
MSCs for cell-based therapeutic applications.
2. Materials and Methods
2.1. Reagents. Dulbecco’s Modified Eagle Medium (DMEM),
𝛼MEM, foetal bovine serum (FBS), penicillin/streptomycin
(P/S), 0.4% trypan blue stain, and TRIzol were obtained
from Gibco (Invitrogen, Carlsbad, CA, USA). Mesenchymal
stem cell growth medium (MSCGM), osteogenic differen-
tiation medium, adipogenic differentiation medium, and
chondrocyte differentiation medium were obtained from
Cambrex (Lonza, Allendale, NJ, USA). Poly-L-lysine (PLL)
and propidium iodide (PI) were purchased from Sigma-
Aldrich (St. Louis, MO, USA). The senescence detection
kit was obtained from BioVision Inc. Oligonucleotides for
polymerase chain reaction (PCR), reverse transcription, and
cDNA were synthesized by Bioneer (Bioneer Corporation,
Daejeon, Korea). Silver nitrate, oil red O, and safranin O for
differentiation staining were purchased from Sigma-Aldrich.
2.2. Cell Culture. MSCs were isolated from human bone
marrow as previously described [25]. Cells after informed
consent were collected from healthy three donors with
approval from the Research Ethics Committee of Severance
Hospital (Approval number 4-2014-0650). Primary cells of
passage 0 were cultured and maintained in low glucose
DMEM (DMEM-LG) supplemented with 10% FBS and 1%
P/S at 37∘C in 5% CO
2
. Cells were harvested using 0.05%
trypsin/EDTA (Invitrogen) when they reached 80–90% con-
fluence for further experiment. Harvested 2 × 104 cells/well in
12-well plates were replated in 0.01% PLL-coated or uncoated
plates for all experiments.
2.3. Flow Cytometry Analysis. For immunophenotyping,
MSCs were stained with fluorescein isothiocyanate- (FITC-)
or phycoerythrin- (PE-) conjugated monoclonal antibodies:
CD14-FITC, CD29-FITC, CD31-PE, CD34-FITC, CD44-PE,
CD45-PE, CD73-PE, CD90-FITC, CD105-PE, and CD106-
FITC (all from BD Pharmingen, San Diego, CA, USA).
Additionally, FITC- and PE-conjugated isotype controls were
used as negative controls. Briefly, cultured MSCs were har-
vested and stained with the antibodies for 20min at 4∘C.
Subsequently, the stained cells were washed with phosphate
buffered saline (PBS) and fixed with 1% paraformaldehyde
(Biosesang, Seongnam, Korea).The cells were analysed using
a flow cytometer (Cytomics FlowCytometer; BeckmanCoul-
ter, Fullerton, CA, USA).
2.4. Growth Characteristics. For analysis of cell proliferation,
MSCs were plated at a density of 2 × 104 per well in uncoated
or PLL-coated 12-well plates (Corning Inc., Corning 07-
200-81, NY, USA) in MSC culture medium. Cultures were
maintained for 5 days and then harvested for cell counting on
days 3, 4, and 5.The proliferation rate of cells was determined
using the trypan blue exclusion method. The population
doubling time was calculated as the cumulative number of
serial cells passaging until the cells reached senescence [26].
At passage 7, cells were photographed.
2.5. Cell Cycle Analysis. The culturedMSCs at passage 7 were
removed from uncoated and PLL-coated plates. Harvested
cells washed with PBS and fixed with cold 70% ethanol
while minimizing clumping. After 30min at 4∘C, the cells
were washed with PBS and stained with propidium iodide.
Propidium iodide fluorescence was then examined using the
Cytomics Flow Cytometer (Beckman Coulter).
2.6. 𝛽-Galactosidase Staining. 𝛽-galactosidase staining was
performed using the senescence associated 𝛽-galactosidase
staining kit (BioVision Inc.), according to the manufacturer’s
instructions. Briefly, passage 7 MSCs cultured on uncoated
and PLL-coated plates were washed with PBS and fixed with
4% paraformaldehyde at room temperature. After washing
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Table 1: Primer sequences.
Gene Primer sequence (5󸀠-3󸀠) Annealingtemperature (∘C)
Product
size (bp)
p16INK4a Forward: CGAATAGTTACGGTCGGAGGReverse: GCATGGTTACTGCCTCTGGT 62 309
p21Cip1 Forward: GCGATGGAACTTCGACTTTGReverse: CGTTTTCGACCCTGAGAGAGTC 60 285
SH3 (CD73) Forward: TATTGCACTGGGACATTCGGGTReverse: GGTTGCCCATGTTGCATTCTCT 62 443
SH2 (CD105) Forward: CATCCTTGAAGTCCATGTCCTCTTReverse: GCCAGGTGCCATTTTGCTT 62 95
VCAM-1 (CD106) Forward: GCTTTCCTGCTCCGAAAATCCTReverse: AACTGGGCCTTTCGGATGGTAT 62 367
Oct4 Forward: GACAACAATGAGAACCTTCAGGAGAReverse: TTCTGGCGCCGGTTACAGAACCA 62 218
Sox2 Forward: AACCAAGACGCTCATGAAGAAGReverse: GCGAGTAGGACATGCTGTAGGT 62 341
Nanog Forward: ATAGCAATGGTGTGACGCAGReverse: GATTGTTCCAGGATTGGGTG 62 219
GAPDH Forward: GTGGTCTCCTCTGACTTCAACAReverse: CTCTTCCTCTTGTGCTCTTGCT 62 210
with PBS, cells were incubated with senescence-associated 𝛽-
galactosidase (SA-𝛽-gal) staining solution for 24 h at 37∘C.
The number of 𝛽-galactosidase positive cells (blue colour)
was evaluated under a light microscope (Olympus-IX71), as
an indicator of the number of senescent cells.
2.7. Reverse Transcription PCR (RT-PCR). Total RNA was
prepared using TRIzol reagent, and cDNA was synthe-
sized using transcriptase II (Invitrogen). RT-PCR was per-
formed with PCR primers under the conditions listed in
Table 1 (Bioneer). Glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH) was used as an internal standard. The signal
intensity of the product was normalized to its respective
GAPDH signal intensity.
2.8. DifferentiationAssay. To assess the differentiation poten-
tial of MSCs, cells were seeded at 7 × 104/well in 12-well plates
for the induction of osteogenesis and chondrogenesis and 1.5
× 105/well in 12-well plates for inducing adipogenesis. For
differentiation, primary andpassage 7MSCsweremaintained
for 14 days in osteogenic, adipogenic, or chondrogenic dif-
ferentiation medium (Lonza). For chondrogenesis, cells were
treatedwith 10 ng/mLTGF- (transforming growth factor-)𝛽3
(Lonza). After induction, Von Kossa staining was applied to
analyse osteogenic differentiation, and calcium content was
evaluated using the calcium (CPC) liquicolor kit (Stanbio
Laboratory, Boerne, USA), based on a previously reported
method [27]. Briefly, the cells were washed with PBS and
treated 0.5NHCl. After shaking for 3 hwith an orbital shaker,
the supernatant was transferred to a new tube for analysis.
Ortho-cresolphthalein complexone (OCPC) was added to
the sample, and absorbance was detected at 550 nm. After
adipogenic differentiation, lipid droplets were detected by
oil red O staining, and absorbance was measured at 500 nm
after destaining with isopropanol for 30min for quantitative
analysis according to the previously reportedmethod [27]. To
evaluate chondrogenesis, cells were stained with safranin O
solution, and the absorbance of sulphated glycosaminoglycan
was detected at 656 nm using the Blyscan assay kit (Biocolor
Ltd.) for quantitative analysis. Briefly, the supernatant of each
samplewasmixedwithDMMBdye and reagents according to
themanufacturer’s protocols and reference [28]. Experiments
were performed in triplicate.
2.9. Human Genome Microarray. The synthesis of target
cRNA probes and hybridization were performed using
Agilent’s Low RNA Input Linear Amplification kit (Agilent
Technology, USA), according to the manufacturer’s instruc-
tions. Briefly, 1𝜇g of total RNAandT7 promoter primerswere
mixed and incubated at 65∘C for 10min. The cDNA master
mix (5x first strand buffer, 0.1M DTT, 10mM dNTP mix,
RNase-Out, and MMLV-RT) was prepared and added to the
reaction mix.The samples were incubated at 40∘C for 2 h and
were then incubated at 65∘C for 15min to terminate RT and
dsDNA synthesis.The transcriptionmastermixwas prepared
according to the manufacturer’s protocol (4x transcription
buffer, 0.1MDTT,NTPmix, 50%PEG, RNase-Out, inorganic
pyrophosphatase, T7-RNA polymerase, and cyanine 3/5-
CTP). Transcription of dsDNA was performed by adding
the transcription master mix to dsDNA reaction samples
and incubating at 40∘C for 2 h. Amplified and labelled cRNA
was purified using the cRNA Cleanup Module (Agilent
Technology), according to the manufacturer’s protocol. The
labelled cRNA target was quantified using a ND-1000 spec-
trophotometer (NanoDrop Technologies, Inc., Wilmington,
DE). After checking the labelling efficiency, fragmentation of
cRNA was performed by adding 10x blocking agent and 25x
fragmentation buffer and incubating at 60∘C for 30min. The
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fragmented cRNA was resuspended with 2x hybridization
buffer and directly pipetted onto assembled Agilent’s Human
Oligo Microarray (44K). The arrays hybridized at 65∘C for
17 h using anAgilent hybridization oven (Agilent Technology,
USA). The hybridized microarrays were washed, according
to the manufacturer’s washing protocol (Agilent Technology,
USA).
2.10. Data Acquisition and Analysis. All data normalization
and selection of differentially expressed genes were
performed using GeneSpringGX 7.3 (Agilent Technology,
USA). The averages of normalized ratios were calculated by
dividing the average normalized signal channel intensity by
the average normalized control channel intensity. Functional
annotation of genes was performed according to the Gene
OntologyConsortium (http://www.geneontology.org/index
.shtml) by GeneSpringGX 7.3. Gene classification was based
on searches of the BioCarta (http://www.biocarta.com/),
GenMAPP (http://www.genmapp.org/), DAVID (http://
david.abcc.ncifcrf.gov/), and Medline databases (http://www
.ncbi.nlm.nih.gov/).
2.11. Statistical Analysis. Statistical analysis was performed
using Student’s t-test. Quantitative data are expressed as
means ± SD. Differences are considered statistically signifi-
cant at 𝑝 < 0.05.
3. Results
3.1. Characterization of Cultured MSCs. MSCs were isolated
and cultured from human bone marrow of three different
donors. Cultured MSCs displayed a fibroblast-like morphol-
ogy, and they were differentiated into osteocyte, chondrocyte,
and adipocyte under proper conditions (Figure 1(a)). For
immunophenotyping of cultured MSCs, MSCs derived from
different donors were analysed by flow cytometry. Figure 1(b)
shows that MSCs were positive for MSC markers, including
CD29, CD44, CD73, CD90, and CD105, whereas MSCs were
negative for CD14, CD31, CD34, CD45, and CD106 known as
hematopoietic and endothelial markers. The results of flow
cytometry demonstrate that the cultured cells were typical
MSCs.
3.2. Growth Kinetics of Cultured MSCs on Uncoated and
PLL-Coated Plates. To determine the effect of PLL on in
vitro culture of MSCs, we compared the proliferation activity
of MSCs cultured on uncoated and PLL-coated plates. The
optimal concentration of 0.01% PLL used for this study
was determined empirically, since we observed that high
concentrations greater than 0.01% hindered MSC adhesion
and spread (data not shown). Bone marrow-derived MSCs at
passage 3 were cultured for 5 days to determine whether PLL
stimulates MSC proliferation in the short-term culture. The
numbers of harvested cells at days 3, 4, and 5 were measured
using the trypan blue exclusion method. An increase in
cell numbers was detected in MSCs cultured on PLL-coated
plates compared to cells grown in the absence of PLL-coating
(Figure 1(c)).
3.3. PLL Suppressed MSC Replicative Senescence. Passage 7
MSCs cultured in DMEM on uncoated plates displayed the
typical phenomenon of replicative senescence with morpho-
logical abnormalities (Figure 2(a)). MSCs are typically culti-
vated in DMEM-LG containing 10% FBS and 1% P/S. Addi-
tionally, 𝛼MEM and mesenchymal stem cell growth medium
(MSCGM) are also used for MSC culture. MSCGM is a
known specific medium for mesenchymal stem cell growth.
To investigate morphological changes of replicative senes-
cence of MSCs, cells were replated in 𝛼MEM and MSCGM
with DMEM.MSCs grown in 𝛼MEMandMSCGM exhibited
similar morphological patterns including cell aggregation as
MSCs grown in DMEM (data not shown). Senescent cells
were subsequently seeded on uncoated and PLL-coated plates
to determine whether PLL could induce any changes during
culture. Surprisingly, MSCs seeded on uncoated plates main-
tained an aggregated phenotype with growth arrest, whereas
cells on the PLL-coated plates demonstrated an increased
growth rate without aggregation (Figure 2(a)). The popula-
tion doubling time of MSCs cultured on PLL-coated plates
was decreased compared with that of MSCs on uncoated
plates in culture (Figure 2(a)). Additionally, MSCs cultured
on uncoated plates did not demonstrate further growth;
however MSCs cultured on PLL-coated plates reached 100%
confluence within several days. Furthermore, to examine
whether PLL increased the S-phase, cell cycle analysis was
carried out using flow cytometry. PLL increased the S-
phase of MSCs compared to MSCs cultured in the absence
of PLL (Figure 2(b)). We next investigated whether PLL
suppressed MSC senescence. MSCs cultured on uncoated
and PLL-coated plates were stainedwith𝛽-galactosidase after
the typical phenomenon of senescence was observed. MSCs
cultured on uncoated plates showed a significant increase in
the percentage of 𝛽-galactosidase positive cells compared to
cells cultured on PLL-coated plates (Figure 2(c)).
3.4. PLL Induced Stemness Markers and Inhibited Senescence
Related Genes. The gene expressions of knownMSCmarkers
CD73, CD105, and CD106 in MSCs at passage 7 showing a
senescent phenotype cultured on uncoated and PLL-coated
plates were analysed using RT-PCR analysis. All MSCs,
regardless of cell culture conditions, were positive for CD105
andCD106 (Figure 3(a)). Importantly, very low levels ofCD73
(ecto-5󸀠-nucleotidase), a MSC specific marker, were detected
in senescent MSCs cultured on uncoated plates, whereas it
was distinctly expressed in MSCs cultured on PLL-coated
plates (Figure 3(a)). Oct4, Nanog, and Sox2 that regulate the
maintenance of the pluripotency have been purported to
play a similar role also in mesenchymal stem cells [29, 30].
To determine whether stemness was affected by PLL, we
investigated the gene expression levels of stemness markers
such as Oct4, Sox2, and Nanog. Oct4 was undetectable in all
MSCs regardless of culture conditions. However Sox2 and
Nanog were upregulated in MSCs cultured on PLL-coated
plates compared to senescent MSCs cultured on uncoated
plates (Figure 3(b)). These results indicate that MSC and
stemness markers were affected by PLL. In addition, to
confirmwhether PLL affected cell proliferation, p16INK4a and
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Figure 1: Characteristics and short-term culture of MSCs. (a) Cell morphology was observed under phase-contrast microscopy ((A)
magnification: 100x) and differentiation potential was evaluated by Von Kossa, oil red O, and safranin O staining ((B) osteogenesis-
magnification: 200x, (C) adipogenesis-magnification: 400x; (D) chondrogenesis-magnification: 200x). (b) The immunophenotype of bone
marrow-derived MSCs. Flow cytometry histograms show that cultured MSCs were positive CD29, CD44, CD73, CD90, and CD105. These
results show representative histograms of cultured MSCs. (c) Proliferative activity of cultured MSCs. MSCs were cultured on uncoated or
poly-L-lysine- (PLL-) coated plates for 5 days. The number of harvested cells was measured by trypan blue staining. The data represent the
mean ± standard deviation of three independent experiments (𝑛 = 3). ∗𝑝 < 0.05.
p21Cip1 genes associated senescence were analysed by RT-
PCR. As shown in Figure 3(c), the mRNA expression levels
of p16INK4a and p21Cip1 were decreased in cells cultured on
PLL-coated plates compared to the cells on uncoated plates.
In particular, the decreasing of p21 is statistically signifi-
cant in passage 7 of PLL-coated plate (Figure 3(c)). These
results demonstrate that senescent MSCs can be cultured
normally onPLL-coated plates and that PLL can inhibitMSC-
replicative senescence.
3.5. Differentiation Potential of MSCs Cultured on PLL-Coated
Plates. To assess the differentiation potential of MSCs, cells
at passage 7 showing a senescent phenotype were cultured
and induced to differentiate to osteocytes, adipocytes, and
chondrocytes in specific differentiation media. Von Kossa
staining was used to detect calcium-containing mineralized
nodules indicating osteogenic induction.The results demon-
strated that MSCs cultured on PLL-coated plates showed
higher amounts of Von Kossa staining compared to cells on
uncoated plates, andMSCs cultured onPLL-coated plates had
higher calcium accumulation compared to cells on uncoated
plates in the calcium content assay (Figure 4(a)). Adipogenic
differentiation was analysed by oil red O staining. BothMSCs
cultured on uncoated and PLL-coated plates showed lipid
droplet formation, and the absorbance value for oil red O
staining was similar between the two culture conditions
(Figure 4(b)). The chondrogenic differentiation potential of
MSCs was assessed using safranin O staining. Similar to
the results of adipogenic differentiation, both MSCs had
similar chondrogenic differentiation capacity, as sulphated
glycosaminoglycan content was also similar between MSCs
cultured under both conditions (Figure 4(c)).
3.6. Gene Expression Profiles. Genome-wide expression pro-
files of MSCs were analysed by human genome microarray.
We analysed the expression patterns of senescent MSCs
of the same donor cultured on uncoated and PLL-coated
plates. The most significant differentially expressed genes
are summarized in Tables 2 and 3. Differentially expressed
genes (>twofold) in MSCs cultured on PLL and uncoated
plates were sorted into 8 categories according to function:
cell adhesion, FGF-2 signalling, cell cycle, oxidative stress,
tumorigenicity, stemness, cell differentiation, and cell prolif-
eration.
Upregulated genes included the following: calcium chan-
nel, voltage-dependent, L type, alpha 1C subunit (CACNA1C),
which may play a role in the differentiation of stem cells [31];
delta-like 2 homolog (DLK2), a modulator of adipogenesis
[32]; nuclear assembly factor 1 homolog (NAF1), which is
required for telomerase function [33]; centromere protein I
(CENPI), which is essential for mitosis [34]; apelin (APLN)
that attenuates oxidative stress [35]; actinin, alpha 2 (ACTN2),
which is involved in maintaining the cell spreading and
motility [36]; ciliary neurotrophic factor receptor (CNTFR),
which acts on neuronal populations in the developing and
mature brain [37]; lethal giant larvae homolog 2 (LLGL2),
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Table 2: Upregulated genes (>twofold) in MSCs on uncoated and poly-L-lysine- (PLL-) coated plates.
Gene name Description NCBI PLL/UN
Calcium channel, voltage-dependent, L
type, alpha 1C subunit
Homo sapiens calcium channel, voltage-dependent, L
type, alpha 1C subunit (CACNA1C), transcript NM 001129827 16.55
Delta-like 2 homolog (Drosophila) Homo sapiens delta-like 2 homolog (Drosophila)(DLK2), transcript variant 2 NM 206539 10.97
Nuclear assembly factor 1 homolog (S.
cerevisiae)
Homo sapiens nuclear assembly factor 1 homolog (S.
cerevisiae) (NAF1), transcript variant 1 NM 138386 3.82
Centromere protein I Homo sapiens centromere protein I (CENPI) NM 006733 3.15
Apelin Homo sapiens apelin (APLN) NM 017413 3.07
Actinin, alpha 2 Homo sapiens actinin, alpha 2 (ACTN2) NM 001103 2.89
Ciliary neurotrophic factor receptor Homo sapiens ciliary neurotrophic factor receptor(CNTFR), transcript variant 1 NM 147164 2.84
Lethal giant larvae homolog 2
(Drosophila)
Homo sapiens lethal giant larvae homolog 2
(Drosophila) (LLGL2), transcript variant 3 NM 001031803 2.43
E2F transcription factor 8 Homo sapiens E2F transcription factor 8 (E2F8) NM 024680 2.23
Tyrosine kinase, nonreceptor, 2 Homo sapiens tyrosine kinase, nonreceptor, 2 (TNK2),transcript variant 2 NM 001010938 2.20
Inhibin, beta B Homo sapiens inhibin, beta B (INHBB) NM 002193 2.07
Table 3: Downregulated genes (>twofold) in MSCs on uncoated and poly-L-lysine- (PLL-) coated plates.
Gene name Description NCBI PLL/UN
Hairy/enhancer-of-split related with
YRPWmotif 1
Homo sapiens hairy/enhancer-of-split related to YRPW
motif 1 (HEY1), transcript variant 2 NM 001040708 0.43
Thrombospondin 2 Homo sapiens thrombospondin 2 (THBS2) NM 003247 0.45
Leucine rich repeat containing 17 Homo sapiens leucine rich repeat containing 17(LRRC17), transcript variant 2 NM 005824 0.47
Collagen, type XI, alpha 1 Homo sapiens collagen, type XI, alpha 1 (COL11A1),transcript variant B NM 080629 0.47
Chitinase 3-like 1 (cartilage
glycoprotein-39)
Homo sapiens chitinase 3-like 1 (cartilage
glycoprotein-39) (CHI3L1) NM 001276 0.48
Sulfatase 2 Homo sapiens sulfatase 2 (SULF2), transcript variant 1 NM 018837 0.48
Neurotrophic tyrosine kinase, receptor,
type 2
Homo sapiens neurotrophic tyrosine kinase, receptor,
type 2 (NTRK2), transcript variant c NM 001018064 0.50
involved in normal cell division [38]; E2F transcription factor
8 (E2F8), which plays an important role in the S-phase of
the cell cycle [39]; tyrosine kinase, nonreceptor, 2 (TNK2),
which inhibits the GTPase activity of p21 [40]; inhibin beta B
(INHBB), which is involved in self-renewal of stem cells [41].
Downregulated genes included the following: hairy/
enhancer-of-split related to YRPWmotif 1 (HEY1), a tumour
specific gene [42]; thrombospondin 2 (THBS2), which medi-
ates focal adhesion disassembly [43]; leucine rich repeat
containing 17 (LRRC17), a known negative regulator of osteo-
genesis [44]; collagen, type XI, alpha 1 (COL11A1), which is
expressed in tumour cell lines [45]; chitinase 3-like 1 (cartilage
glycoprotein-39, CHI3L1), which is involved in oxidative
stress [46]; sulphates 2 (SULF2), which is upregulated in
cancer [47, 48]; neurotrophic tyrosine kinase, receptor, type
2 (NTRK2), which stimulates focal adhesion disassembly and
is involved in cancer [49, 50].
4. Discussion
Adult stem cells (MSCs) havemany advantages, such as being
less tumorigenic, and they do not trigger immune rejection.
MSCs thus hold significant promise for future use in stem
cell therapy and tissue engineering. However, there are also
disadvantages that currently limit their clinical application.
MSCs exist in low quantity from a variety of sources, and
it is hard to culture them in vitro because they are sensitive
to external stimuli and readily enter a state of replicative
senescence. The culture and expansion of a large amount
of MSCs from primary sources are very important for their
successful clinical application. Therefore, the development
of an easy and innovative method for cultivating MSCs is
critical.
Generally, cells are exposed to complex and highly struc-
tured microenvironments regulated by multiple biophysical
and biochemical factors such as soluble factors and ECM
in vivo [51]. The fate of MSCs is controlled by cell to
cell and cell to ECM interactions [52]. Similarly, in vitro
culture conditions have a significant impact on the fate
of MSCs with changes in gene and protein expression
profiles. ECM proteins constitute a microenvironment that
provides structural support and attachment to the cells
and offer essential communication between cells and their
surrounding environment [53]. In this study, we applied a
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Figure 2: Changes in senescent cells induced by extracellular matrix (ECM) coating. (a) Morphological changes and population doubling
time in senescent cells cultivated on a poly-L-lysine- (PLL-) coated plate were observed compared to cells cultured on an uncoated plate
(magnification: 100x, scale bar = 200 𝜇m). (b) Cell cycle analysis. Cells were removed from the culture well, stained for DNA with propidium
iodide (PI), and analysed by flow cytometry. (c) Senescence associated 𝛽-gal assay of MSCs cultured on uncoated and PLL-coated plates. One
representative of three independent experiments is shown. The number of 𝛽-gal positive cells was enumerated. The data represent the mean
± standard deviation of three experiments (magnification: 200x, scale bar = 100 𝜇m). ∗∗𝑝 < 0.01.
cell culture condition, in which MSCs were grown on plates
coated with PLL, which is known to promote cell adhesion
to solid substrates and to recreate the in vivo microen-
vironment. We observed an increase in the number of MSCs
cultured on PLL-coated plates with activation of the S-phase
of the cell cycle. These results indicate the positive effects
of PLL on the proliferation of MSCs in in vitro culture.
In addition, PLL retarded MSC replicative senescence, as
determined by 𝛽-galactosidase staining, demonstrating that
PLL-coated plates provide the necessary microenvironment
for optimal growth of MSCs in vitro. Interestingly, CD73,
ecto-5󸀠-nucleotidase used as a marker for MSCs, was rarely
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Figure 3: Gene expression of cells cultured on uncoated and poly-L-lysine- (PLL-) coated plates. Gene expression was analysed by RT-PCR
for (a) MSC and (b) stemness markers. (c) p16INK4a and p21Cip1 mRNA expression levels were evaluated using RT-PCR. Expression level
relative to that of housekeeping gene GAPDH is shown. ∗∗𝑝 < 0.01.
expressed in senescent MSCs, whereas MSCs cultured on
PLL-coated plates strongly expressed this marker. It is known
that most cells that express CD73 are responsible for the
production of extracellular adenosine; however its specific
function in MSCs is not fully understood. CD73 may be
associated with replicative senescence and be a marker of
MSC senescence as indicated by our findings (Figure 3(a)).
Oct4, Sox2, and Nanog, which are known pluripotency and
stemness markers, are very important for self-renewal of
stem cells, and they play an essential role in generating
induced pluripotent stem cells [54]. Sox2 is also recently
known that it is important inmaintenance of cell proliferation
and multipotency of MSC [55]. Normally, Oct4 that is a key
transcription factor essential for survival and self-renewal is
expressed in adult stem cells. However, the expression ofOct4
easily disappears during culture in vitro [56].Oct4was in our
study undetectable because genes concerning pluripotency
including Oct4, Sox2, and Nanog were analysed in passage
7MSCs. Our results demonstrated that Sox2 and Nanog are
significantly upregulated in MSCs cultured on PLL-coated
plates compared with MSCs cultured on uncoated plates.
Upregulation of those stemness factors may play a crucial
role in increasing MSC proliferation and delaying replicative
senescence of MSCs. Moreover, our results suggest that PLL
can significantly improve osteogenic differentiation of MSCs.
MSCs could not ordinarily differentiate into osteocytes due to
cell aggregation and inhibition of proliferation in osteogenic
induction environment. However, PLL had no effect on
the adipogenic and chondrogenic differentiation capacity of
MSCs.
In this study, we present for the first time an anal-
ysis of the global gene expression profiles of senescent
MSCs cultured on uncoated versus PLL-coated plates, using
human genome microarray to gain insight into the molec-
ular characteristics of senescence. Functional classification
of differentially expressed genes, according to the Gene
Ontology (GO), demonstrated that genes associated with
the cell cycle (GO:0007049), cell division (GO:0051301),
cell proliferation (GO:0008283), transcription factor activity
(GO:0003700), extracellular region (GO:0005576), positive
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Figure 4: Differentiation potential of cells cultured on uncoated and poly-L-lysine- (PLL-) coated plates. (a) Osteogenesis was determined by
VonKossa staining and calciumquantification. (b)Adipogenesis was examined by oil redO staining. For quantitative analysis, absorbancewas
detected after destaining. (c) Chondrogenesis was analysed by safranin O staining and glycosaminoglycan quantification. The data represent
the mean ± standard deviation of three independent experiments. ∗𝑝 < 0.05.
regulation of cell proliferation (GO:0008284), and focal adhe-
sion (GO:0005925) were upregulated in MSCs cultured on
PLL-coated plates compared to MSCs cultured on uncoated
plates. These findings are in line with the increased prolif-
eration potential of MSCs cultured on PLL-coated plates.
Several genes related to cell proliferation might also act as
inhibitors of MSC senescence. However, to determine the
role of individual genes on MSC, additional studies will be
required.
Several studies have reported that MSCs undergo a
typical phenomenon of replicative senescence with changing
cell morphology and decreasing proliferation under in vitro
culture. We determined that senescence of bone marrow-
derived MSCs occurred after 6 passages. Such senescence
is considered to be associated with the accumulation of
intracellular reactive oxygen species (ROS) and shortening
of telomere length [57]. High levels of ROS are associated
with the loss of stemness, and growth arrest is triggered by
the p53 and p21 pathways [58, 59]. In this study, we showed
that the cell senescence was inhibited by PLL through the
suppression of p16INK4a and p21Cip1mRNA expression levels.
Based on those mechanisms, it was recently reported that
cellular senescence of MSCs could be inhibited via FGF-
2 mediated suppression of p53 and p21 [60]. Overall, our
study showed that PLL induces the upregulation of genes
involved in cell adhesion, FGF-2 signalling, cell cycle reg-
ulation, stemness, cell differentiation, and cell proliferation
with downregulation of genes associated with oxidative stress
and tumorigenicity. Changes in those genes corresponded to
significant suppression ofMSC senescence by PLL.The genes
affected by PLL are summarized in Tables 2 and 3. Our results
require further investigation as to the specific genes that have
functional implications on senescent MSCs.
Cellular senescence is generally considered an irreversible
cellular change. In our study, the proliferation capacity and
functionality of senescent MSCs were improved by PLL;
however this effect of PLL was reversed when these cells
were recultured in the absence of PLL on uncoated plates
(data not shown). PLL as a coating substrate affects senescent
MSCs when the cells attached on PLL through cell to ECM
interaction. Therefore, senescent MSCs on uncoated plates
could return to a senescence phenotype if they were not
maintained on PLL-coated culture vessels. Previously, Yocum
et al. reported that infusing cells labeled with ferumoxides-
PLL complex does not affect hematologic or biochemical
measures [61]. MSCs cultured on and mixed with PLL may
be useful for clinical application because PLL definitely
enhances functionality, and it does not alter biochemical and
hematologic measurements in vivo.
In conclusion, we established an easy and simple culture
system for culturing MSCs. Our system enhanced the prolif-
eration rates of MSCs and evokes consistent changes in gene
expression associated with MSC stemness markers and dif-
ferentiation potential. We conclude that senescent MSCs can
BioMed Research International 11
be converted to a normal-like state using PLL. Improvement
of the MSC culture system in vitro will contribute greatly
to the development of cell-based therapy and regenerative
medicine.
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